Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFLD); by contrast, the role of anti-inflammatory molecules has not been addressed. Low circulating levels of the anti-inflammatory molecule IGF-I have been described in subjects with NAFLD.

Hribal, M., Procopio, T., Petta, S., Sciacqua, A., Grimaudo, S., Pipitone, R., et al. (2013). Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 98(2), E304-E308 [10.1210/jc.2012-3290].

Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease

PETTA, Salvatore;GRIMAUDO, Stefania;PIPITONE, Rosaria Maria;
2013

Abstract

Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFLD); by contrast, the role of anti-inflammatory molecules has not been addressed. Low circulating levels of the anti-inflammatory molecule IGF-I have been described in subjects with NAFLD.
Hribal, M., Procopio, T., Petta, S., Sciacqua, A., Grimaudo, S., Pipitone, R., et al. (2013). Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 98(2), E304-E308 [10.1210/jc.2012-3290].
File in questo prodotto:
File Dimensione Formato  
IGF1 JCEM.pdf

Solo gestori archvio

Dimensione 209.72 kB
Formato Adobe PDF
209.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/73250
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 50
social impact